Literature DB >> 12508608

Cognition and the inhibitory control of saccades in schizophrenia and Parkinson's disease.

T J Crawford1, D Bennett, G Lekwuwa, S Shaunak, J F W Deakin.   

Abstract

Historically, various lines of evidence have converged on the view that the brain expends much of its neural resources on inhibiting its own activity in a critical step towards the cognitive control of behaviour. The loss of inhibitory control is widely reported in neurological and psychiatric disorders; however, the consequences of reduced inhibition in terms of wider cognitive effects on cognitive control operations such as planning, abstract thought, working memory and the ability to appreciate the perspective of others ('theory of mind') has been widely overlooked. The antisaccade paradigm examines the conflict between a prepotent stimulus that produces a powerful urge to fixate the target, and the overriding goal to 'look' in the opposite direction. In this chapter we illustrate how this paradigm is increasingly used to explore the relationship of inhibitory control and cognition in Parkinson's disease, schizophrenia and healthy participants. Evidence is presented that is consistent with the theory of cognitive inhibition as a distinct process that can be dissociated from working memory. We conclude that the inhibitory control of saccadic eye movement should be studied in the wider context of cognitive operations.

Entities:  

Mesh:

Year:  2002        PMID: 12508608     DOI: 10.1016/S0079-6123(02)40068-4

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  16 in total

1.  Executive control in chronic schizophrenia: A perspective from manual stimulus-response compatibility task performance.

Authors:  Simone D Behrwind; Manuel Dafotakis; Sarah Halfter; Kerstin Hobusch; Mark Berthold-Losleben; Edna C Cieslik; Simon B Eickhoff
Journal:  Behav Brain Res       Date:  2011-04-14       Impact factor: 3.332

2.  Is the relationship of prosaccade reaction times and antisaccade errors mediated by working memory?

Authors:  Trevor J Crawford; Elisabeth Parker; Ivonne Solis-Trapala; Jenny Mayes
Journal:  Exp Brain Res       Date:  2010-11-25       Impact factor: 1.972

3.  Reflexive and volitional saccades: biomarkers of Huntington disease severity and progression.

Authors:  Saumil S Patel; Joseph Jankovic; Ashley J Hood; Cameron B Jeter; Anne B Sereno
Journal:  J Neurol Sci       Date:  2011-10-21       Impact factor: 3.181

4.  Behavioral responses of trained squirrel and rhesus monkeys during oculomotor tasks.

Authors:  Shane A Heiney; Pablo M Blazquez
Journal:  Exp Brain Res       Date:  2011-06-09       Impact factor: 1.972

5.  Disruption of Fixation Reveals Latent Sensorimotor Processes in the Superior Colliculus.

Authors:  Uday K Jagadisan; Neeraj J Gandhi
Journal:  J Neurosci       Date:  2016-06-01       Impact factor: 6.167

6.  The role of working memory and attentional disengagement on inhibitory control: effects of aging and Alzheimer's disease.

Authors:  Trevor J Crawford; Steve Higham; Jenny Mayes; Mark Dale; Sandip Shaunak; Godwin Lekwuwa
Journal:  Age (Dordr)       Date:  2012-08-18

7.  Impaired control of the oculomotor reflexes in Parkinson's disease.

Authors:  Martijn G van Koningsbruggen; Tom Pender; Liana Machado; Robert D Rafal
Journal:  Neuropsychologia       Date:  2009-06-26       Impact factor: 3.139

8.  Antisaccade Deficits in Schizophrenia Can Be Driven by Attentional Relevance of the Stimuli.

Authors:  Sonia Bansal; John M Gaspar; Benjamin M Robinson; Carly J Leonard; Britta Hahn; Steven J Luck; James M Gold
Journal:  Schizophr Bull       Date:  2021-03-16       Impact factor: 9.306

Review 9.  The neural bases of obsessive-compulsive disorder in children and adults.

Authors:  Tiago V Maia; Rebecca E Cooney; Bradley S Peterson
Journal:  Dev Psychopathol       Date:  2008

10.  Probing the attentional control theory in social anxiety: an emotional saccade task.

Authors:  Matthias J Wieser; Paul Pauli; Andreas Mühlberger
Journal:  Cogn Affect Behav Neurosci       Date:  2009-09       Impact factor: 3.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.